Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Metabolic subtyping based on dynamic network biomarker reveals potential therapeutic targets in hepatocellular carcinoma

PROVIDER: PRJNA802641 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR17854062_1.fastq.gz	Fastqsanger.gz
	SRR17854062_2.fastq.gz	Fastqsanger.gz
	SRR17854063_1.fastq.gz	Fastqsanger.gz
	SRR17854063_2.fastq.gz	Fastqsanger.gz
	SRR17854064_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 60

Similar Datasets

Metabolic subtyping based on dynamic network biomarker reveals potential therapeutic targets in hepatocellular carcinoma

Project description:Metabolic subtyping based on dynamic network biomarker reveals potential therapeutic targets in hepatocellular carcinoma

| PRJNA802721 | ENA

Project description:Dynamic Network Curvature Analysis of Gene Expression Reveals Novel Potential Therapeutic Targets in Sarcoma

| PRJNA1046425 | ENA

miRNA expression profiles in the liver of a NASH-HCC model mice

Project description:To identify miRNAs that play important roles in the liver carcinogenesis from NASH, miRNA expression profiles were examined. Some miRNAs showed aberrant expression in HCC (Hepatocellular carcinoma) from NASH (non-alcoholic steatohepatitis). These miRNAs were regulated by DNA methylation, and could be potential therapeutic targets for HCC (Hepatocellular carcinoma) from NASH (non-alcoholic steatohepatitis).

2014-12-01 | GSE52821 | GEO

miRNAs expression profiles in HepG2 cells treated with SAHA and/or 5-Aza-CdR

2014-12-01 | GSE52820 | GEO

Circulating extracellular vesicle-derived microRNAs as novel diagnostic and prognostic biomarkers for non-viral-related hepatocellular carcinoma

Project description:The potential significance of plasma extracellular vesicle-derived miRNAs in non-hepatitis B-, non-hepatitis C-related hepatocellular carcinoma as biomarker for the diseases was explored.

2023-10-11 | GSE244605 | GEO

Evaluation the targeted nanobubbles mediated LND against hepatocellular carcinoma by sonodynamic therapy with RNA-Seq

Project description:Sonodynamic therapy is an important approach in the treatment of hepatocellular carcinoma. A novel targeted nanobubbles loaded with HMME and LND was structured as sensibilizer, characterized the properties, and studied therapeutic effect on hepatocellular carcinoma. Next-generation high throughput RNA sequencing (RNA-Seq) was performed to accurately analyze the differential expression of mRNAs and lncRNA targets in hepatocellular carcinoma after sonodynamic therapy.

2022-03-02 | GSE171857 | GEO

Project description:Circulating mRNA variants as a potential biomarker for surveillance of hepatocellular carcinoma

| PRJNA907745 | ENA

Project description:RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma

| PRJNA739257 | ENA

Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor SGI-110 in Hepatocellular Carcinoma Cells [gene expression]

Project description:There is an urgent need for developing more effective therapies for aggressive hepatocellular carcinoma (HCC). Guadecitabine (SGI-110) is a second-generation DNA methyltransferase inhibitor (DNMTi) currently in clinical trials for HCC and shows greater stability and performance over first generation DNMTis. The aim of this study is to identify potential therapeutic targets of SGI-110 for clinical trials.

2018-06-26 | GSE105065 | GEO